|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
DE3374837D1
(en)
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
DE3474511D1
(en)
|
1983-11-01 |
1988-11-17 |
Terumo Corp |
Pharmaceutical composition containing urokinase
|
|
US4808608A
(en)
|
1986-01-23 |
1989-02-28 |
Merck & Co., Inc. |
Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
|
|
US5374426A
(en)
|
1986-09-03 |
1994-12-20 |
University Of Saskatchewan |
Rotavirus nucleocapsid protein VP6 in vaccine compositions
|
|
US4863457A
(en)
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
|
US5164188A
(en)
|
1989-11-22 |
1992-11-17 |
Visionex, Inc. |
Biodegradable ocular implants
|
|
US5459255A
(en)
|
1990-01-11 |
1995-10-17 |
Isis Pharmaceuticals, Inc. |
N-2 substituted purines
|
|
US5218105A
(en)
|
1990-07-27 |
1993-06-08 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
KR0185215B1
(ko)
|
1990-11-30 |
1999-05-01 |
요시다 쇼오지 |
서방성 안구삽입용 약제
|
|
EP0563091A1
(en)
|
1990-12-20 |
1993-10-06 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccines based on hepatitis b surface antigen
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
US5470582A
(en)
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
|
FR2693813B1
(fr)
|
1992-07-20 |
1994-08-19 |
Commissariat Energie Atomique |
Procédé de réalisation d'une image de référence synthétisée à partir de données contenues dans une base de données CAO.
|
|
FR2705099B1
(fr)
|
1993-05-12 |
1995-08-04 |
Centre Nat Rech Scient |
Oligonucléotides phosphorothioates triesters et procédé de préparation.
|
|
CN1185811A
(zh)
|
1995-03-31 |
1998-06-24 |
H·沃尔夫 |
依赖于逆转录病毒样颗粒的抗原呈递系统
|
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
|
EP0880046B1
(en)
|
1996-10-14 |
2010-03-17 |
Seiko Epson Corporation |
Method of manufacturing progressive multifocal lens
|
|
DE69929232T2
(de)
|
1998-10-21 |
2006-08-31 |
The United States Government As Represented By The Department Of Health And Human Services |
Virusähnliche partikel zur induktion von autoantikörpern
|
|
MXPA01005389A
(es)
|
1998-11-30 |
2003-03-27 |
Cytos Biotechnology Ag |
Presentacion molecular ordenada de antigenos, metodos de preparacion y uso.
|
|
DE60122300T2
(de)
|
2000-04-07 |
2007-08-30 |
The University Of Leeds |
Hepatitis b kernprotein fusionsproteine
|
|
CA2407897A1
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
AU2001266163B2
(en)
|
2000-06-22 |
2006-07-13 |
Celltech Pharmaceticals Limited |
Modification of hepatitis b core antigen
|
|
US20030138769A1
(en)
|
2000-08-16 |
2003-07-24 |
Birkett Ashley J. |
Immunogenic HBc chimer particles having enhanced stability
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
DE10201743C2
(de)
|
2002-01-18 |
2003-12-18 |
Aesculap Ag & Co Kg |
Intramedulläres Osteosyntheseimplantat
|
|
AU2003281200A1
(en)
|
2002-07-03 |
2004-01-23 |
Tasuku Honjo |
Immunopotentiating compositions
|
|
US7138252B2
(en)
|
2002-07-17 |
2006-11-21 |
Cytos Biotechnology Ag |
Molecular antigen arrays
|
|
EP2338510A1
(en)
|
2002-07-19 |
2011-06-29 |
Novartis Pharma AG |
Vaccine compositions containing amyloid beta1-6 antigen arrays
|
|
ATE390205T1
(de)
|
2002-12-10 |
2008-04-15 |
Haldor Topsoe As |
Verfahren zur katalytischen dehydrierung und katalysator dafür
|
|
AU2004224761A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US8003619B2
(en)
|
2004-12-09 |
2011-08-23 |
Alnylam Pharmaceuticals, Inc. |
Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
CA2608579C
(en)
|
2005-05-26 |
2019-09-10 |
Cytos Biotechnology Ag |
Scalable fermentation process
|
|
EP1736538A1
(en)
|
2005-06-21 |
2006-12-27 |
Cytos Biotechnology AG |
Process for the preparative purification of virus-like-particles (VLPs)
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
ES2911034T3
(es)
|
2006-08-08 |
2022-05-17 |
Univ Bonn Rheinische Friedrich Wilhelms |
Estructura y uso de oligonucleótidos 5' fosfato
|
|
BR122017025062B8
(pt)
|
2007-06-18 |
2021-07-27 |
Merck Sharp & Dohme |
anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
|
|
DK2176408T5
(en)
|
2008-01-31 |
2015-12-14 |
Curevac Gmbh |
Nucleic acids comprising FORMULA (NuGiXmGnNv) a AND DERIVATIVES AS IMMUNE STIMULATING AGENTS / ADJUVANTS.
|
|
WO2009141146A1
(en)
|
2008-05-21 |
2009-11-26 |
Gunther Hartmann |
5' triphosphate oligonucleotide with blunt end and uses thereof
|
|
US20110184045A1
(en)
|
2008-06-30 |
2011-07-28 |
Gunther Hartmann |
Silencng and rig-i activation by dual function oligonucleotides
|
|
JP2012500855A
(ja)
|
2008-08-25 |
2012-01-12 |
アンプリミューン、インコーポレーテッド |
Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法
|
|
CA2735860A1
(en)
|
2008-09-02 |
2010-03-11 |
Alnylam Pharmaceuticals, Inc. |
Synthetic methods and derivatives of triphosphate oligonucleotides
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2508530A1
(en)
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Purification of triphosphorylated oligonucleotides using capture tags
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
WO2013064584A1
(en)
|
2011-10-31 |
2013-05-10 |
Riboxx Gmbh |
Double-stranded RNA for immunostimulation
|
|
KR101764096B1
(ko)
|
2011-11-28 |
2017-08-02 |
메르크 파텐트 게엠베하 |
항-ｐｄ-ｌ1 항체 및 그의 용도
|
|
WO2013097965A1
(en)
|
2011-12-30 |
2013-07-04 |
Riboxx Gmbh |
Triphosphate-containing double-stranded rna for immunostimulation
|
|
HK1203971A1
(en)
|
2012-05-15 |
2015-11-06 |
Bristol-Myers Squibb Company |
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
|
|
WO2013180295A1
(ja)
|
2012-06-01 |
2013-12-05 |
日本電信電話株式会社 |
パケット転送処理方法およびパケット転送処理装置
|
|
EP2712870A1
(en)
|
2012-09-27 |
2014-04-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Novel RIG-I ligands and methods for producing them
|
|
WO2014093924A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
US20140287023A1
(en)
|
2013-02-11 |
2014-09-25 |
Mcgill University |
5'-triphosphate oligoribonucleotides
|
|
US20160022840A1
(en)
|
2013-03-09 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
WO2014159990A1
(en)
*
|
2013-03-13 |
2014-10-02 |
Yale University |
Interferon production using short rna duplexes
|
|
WO2014169049A1
(en)
*
|
2013-04-09 |
2014-10-16 |
Duke University |
2' fluoro-modified rnas as immunostimulators
|
|
US9775894B2
(en)
|
2013-07-09 |
2017-10-03 |
University Of Washington Through Its Center For Commercialization |
Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
|
|
WO2015038746A1
(en)
|
2013-09-11 |
2015-03-19 |
Georgia Tech Research Corporation |
Compositions and methods for inhibiting gene expression
|
|
WO2015091578A1
(en)
|
2013-12-16 |
2015-06-25 |
Riboxx Gmbh |
Double-stranded polyc:poly(g/i) rna for immunostimulation and cancer treatment
|
|
EP3126501A1
(en)
|
2014-03-24 |
2017-02-08 |
RiboxX GmbH |
Double-stranded rna conjugates and their use
|
|
US9300829B2
(en)
|
2014-04-04 |
2016-03-29 |
Canon Kabushiki Kaisha |
Image reading apparatus and correction method thereof
|
|
CA2953336C
(en)
|
2014-07-15 |
2023-03-21 |
Drifire, Llc |
Lightweight, dual hazard fabrics
|
|
EP3172324A4
(en)
|
2014-07-18 |
2018-04-25 |
Oregon Health & Science University |
5'-triphosphate oligoribonucleotides
|
|
DK3237446T3
(en)
|
2014-12-22 |
2021-07-26 |
Pd 1 Acquisition Group Llc |
Anti-PD-1-antistoffer
|
|
WO2017121494A1
(en)
|
2016-01-15 |
2017-07-20 |
Riboxx Gmbh |
5'-triphosphated short immunostimulatory nucleotides, oligonucleotides and polynucleotides
|
|
WO2017173427A1
(en)
|
2016-04-01 |
2017-10-05 |
Vycellix Inc |
Novel rna construct and methods of use thereof for enhancing the therapeutic effects of cytotoxic cells and stem cells
|
|
CA3061077A1
(en)
|
2016-04-26 |
2017-11-02 |
Qu Biologics Inc. |
Therapeutically triggering an innate immune response in a target tissue
|
|
WO2017221076A1
(en)
|
2016-06-24 |
2017-12-28 |
Institut Pasteur |
Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
|
|
US11382966B2
(en)
*
|
2017-03-24 |
2022-07-12 |
Rigontec Gmbh |
Method for designing RIG-I ligands
|
|
US10736957B2
(en)
*
|
2017-12-19 |
2020-08-11 |
President And Fellows Of Harvard College |
Enhanced immunogenicity of mRNA with co-encoded adjuvant sequences
|
|
CA3086040A1
(en)
*
|
2017-12-19 |
2019-06-27 |
Blaze Bioscience, Inc. |
Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof
|
|
BR112020020479A2
(pt)
|
2018-04-09 |
2021-01-12 |
Checkmate Pharmaceuticals |
Empacotamento de oligonucleotídeos em partículas similares a vírus
|
|
JP7366057B2
(ja)
|
2018-04-19 |
2023-10-20 |
チェックメイト ファーマシューティカルズ， インコーポレイテッド |
合成ｒｉｇ－ｉ様受容体アゴニスト
|
|
CN112369115B
(zh)
|
2018-05-08 |
2024-11-08 |
瑞典爱立信有限公司 |
用于实现业务管理的方法和节点
|
|
EP3810151B1
(en)
*
|
2018-06-20 |
2025-08-06 |
Yale University |
Rig-i agonists and treatments using same
|
|
JP7707161B2
(ja)
|
2019-10-23 |
2025-07-14 |
チェックメイト ファーマシューティカルズ， インコーポレイテッド |
合成ｒｉｇ－ｉ様受容体アゴニスト
|
|
CN115376873A
(zh)
|
2021-05-18 |
2022-11-22 |
江苏鲁汶仪器有限公司 |
离子源装置及其使用方法和真空处理系统
|